HOYA stock
Price history
−2.24% over the period1 year: from ¥23,920.00 (November 17, 2025) to ¥23,385.00 (November 16, 2026), −2.24%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | ¥23,385.00 |
| October 30, 2026 | ¥26,210.00 |
| September 30, 2026 | ¥23,580.00 |
| August 31, 2026 | ¥24,600.00 |
| July 31, 2026 | ¥24,675.00 |
| June 30, 2026 | ¥25,950.00 |
| May 29, 2026 | ¥27,080.00 |
| April 30, 2026 | ¥29,100.00 |
| March 31, 2026 | ¥26,550.00 |
| February 27, 2026 | ¥28,265.00 |
| January 30, 2026 | ¥25,870.00 |
| December 30, 2025 | ¥23,685.00 |
| November 28, 2025 | ¥23,450.00 |
| November 17, 2025 | ¥23,920.00 |
At a glance
The company
Med-tech company providing eyeglasses, contact lenses, medical endoscopes, intraocular lenses, surgical instruments and semiconductor manufacturing products
Latest results
Quarter to September 30, 2026 · EPS ¥211.83 (estimate ¥194.40)
TickerLandia's take on HOYA
- Priced as usual relative to earnings: P/E on the latest fiscal year 31 vs a median of 31 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 29 vs 43 (−33%) in a group of 11.
- Strong point: Financial strength (95/100 in its group). Weak point: Market momentum (40/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−23.08% from the 52-week high
Analysts · 18 analysts
Average target¥30,561.11+30.69% vs. price
Buy 15 · Hold 3 · Sell 0 · Buy
TickerLandia Fingerprint: HOYA
Compared with similar companies: very high financial strength and very high profitability.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Pricehigh66
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 28.7 35 EV/EBITDA 18.1 57 Price/book 7.86 81 Price/sales 7.87 78 Forward P/E 35.0 78 Profitabilityvery high86
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 55.8% 54 Net margin 28.0% 96 ROE 27.7% 90 ROA 16.8% 96 Operating margin 34.4% 96 Earnings stabilityhigh68
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.7% 72 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthhigh68
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +9.41% 72 Revenue growth (year over year) +10.70% 81 Earnings growth (year over year) +30.80% 50 Financial strengthvery high95
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 154.3 95 Debt/equitycounts in reverse: lower means more financial strength 0.04 92 Current ratio 4.69 93 Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −1.46 98 Dividendaverage55
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 26 years 60 Dividend yield 1.4% 59 Payout ratio 39.6% 48 Market momentumweak40
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +1.17% 47 1-year return −1.64% 43 Relative strength (6 months) −10.08% 32 Distance from 200-day average −8.64% 36 Risklow34
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 25.6% 31 Volatility (60 days) 29.8% 32 Beta (1 year) 0.56 38
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
HOYA is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2026), HOYA's P/E today is 31.4, in line with the median of its last 10 fiscal years (30.7; between 20.6 and 38.8 from 2017 to 2026). HOYA's P/E (trailing 12 months): 28.7, −33% against the median of a group of 11 similar companies (43.1).
Compared with 11 similar companies
| Metric | HOYA | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 28.7 | Middle | |
| Forward P/E | 35.0 | Middle | |
| Operating margin | 34.4% | High | |
| ROE | 27.7% | High | |
| Debt/equity | 0.04 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: HOYA. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥259.12B
Latest quarter · Q3 2026
Net income
¥70.71B
Latest quarter · Q3 2026
Quarterly net margin
27.3%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ¥7.93T
- P/E
- 28.7
- EPS
- ¥833.33
- Volume
- 903.1K
- Daily trading
- €208.4M
- Dividend yield
- 1.41%
- Last ex-dividend on September 29, 2026
How HOYA is changing
All resultsRevenue grew 11.6% a year on average over the last 5 years
Operating margin rose from 29.0% to 32.4%
Profits turn into cash: free cash flow equal to 93% of net income
Returns
HOYA returns with dividends
¥1,000 invested in HOYA 5 years ago, on November 16, 2021, would be worth ¥1,374 today with dividends reinvested: +37.39% in total, +6.56% per year. On price alone it would be ¥1,311 (+31.12%).
| Period | HOYA | Nikkei 225 | ¥1,000 becomes |
|---|---|---|---|
| 1 month | −8.83% | −6.39% | ¥912 |
| 6 months | −16.50% | −0.42% | ¥835 |
| Year to date | −1.27% | +21.48% | ¥987 |
| 1 year | −0.94% | +21.52% | ¥991 |
| 3 years | +47.36% | +82.95% | ¥1,474 |
| 5 years | +37.39% | +105.15% | ¥1,374 |
| 10 years | +478.24% | +242.35% | ¥5,782 |
Over the last 6 months it has done better than 10% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. Nikkei 225: price only. Calculate your investment
The chart in detail
HOYA: technical analysis
HOYA shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 22.1% below its all-time closing high (¥30,030.00, April 15, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 39
- Between 30 and 70
- vs 200-session average
- −10.68%
Support and resistance
Price areas where HOYA has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance¥26,038.00+11.34%5 touches, last on May 25, 2026
- Resistance¥25,060.00+7.16%2 touches, last on June 26, 2026
- Resistance¥24,241.67+3.66%6 touches, last on July 8, 2026
- Last price¥23,385.00
- Support¥23,335.00−0.21%3 touches, last on July 29, 2026
Volatility and risk
Over the last year it has moved less than the Nikkei 225.
- Beta (1 year) vs Nikkei 225
- 0.56
- Volatility (60 sessions, annualised)
- 30.1%
- Largest fall in the last year
- −25.64%
Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
HOYA: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for HOYA has been October: +4.27% on average, positive in 25 years out of 37. The weakest has been August: −0.69% on average, positive in 19 years out of 37. November, the current month, has been positive in 19 years out of 36 (+1.00% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.50% | −1.23% | 16 of 36 |
| February | +0.14% | 0.00% | 18 of 37 |
| March | +1.93% | +2.02% | 20 of 37 |
| April | +1.82% | 0.00% | 18 of 37 |
| May | +1.58% | +2.00% | 20 of 37 |
| June | −0.50% | 0.00% | 18 of 37 |
| July | +2.89% | +1.83% | 25 of 37 |
| August | −0.69% | +0.36% | 19 of 37 |
| September | −0.38% | +0.72% | 19 of 37 |
| October | +4.27% | +2.70% | 25 of 37 |
| November | +1.00% | +0.94% | 19 of 36 |
| December | +2.35% | +2.73% | 23 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
HOYA and its competitors
Life Care, the first of the two segments, covers eyeglasses and contact lenses, medical endoscopes, intraocular lenses, and laparoscopic surgical instruments, along with endoscope cleaning equipment and implant-related materials for orthopedics, neurosurgery and dentistry. Through its Eyecity chain it also sells contact lenses directly at retail. The Information and Communications segment supplies mask blanks and photomasks for semiconductor chips and flat panel displays, glass disks for hard disk drives, and optical glass and lenses. The group sells across Japan, Asia, the Americas, Europe and other regions.
- Headquarters
- Shinjuku, Japan
- Employees
- 37,752
- Founded
- 1941
- Chief executive
- Eiichiro Ikeda
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| HOYA7741 | $49.59B | 34.4% | 28.7 | −16.50% |
| Resmed CdiRMD | $33.37B | 34.0% | 21.7 | +24.25% |
| Fisher And Paykel Healthcare CorpoFPH | $15.77B | 27.6% | 55.6 | +46.57% |
| Lenskart SolutionsLENSKART | $13.36B | 10.5% | 161.2 | +56.57% |
| AnsellANN | $4.42B | 15.0% | 21.9 | +80.23% |
| MedlineMDLN | $51.94B | 5.4% | 89.7 | +1.96% |
Same industry or related industries, similar size. Compare HOYA with its competitors · Full profile
